首页|Yunnan Cancer Hospital Reports Findings in Hypertrophic Cardiomyopathy (Machine learning and experimental validation of novel biomarkers for hypertrophic cardio myopathy and cancers)
Yunnan Cancer Hospital Reports Findings in Hypertrophic Cardiomyopathy (Machine learning and experimental validation of novel biomarkers for hypertrophic cardio myopathy and cancers)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Heart Disorders and Di seases - Hypertrophic Cardiomyopathy is thesubject of a report. According to ne ws reporting from Yunnan, People’s Republic of China, by NewsRxjournalists, res earch stated, “Hypertrophic cardiomyopathy (HCM) is a hereditary cardiac disorde r markedby anomalous thickening of the myocardium, representing a significant c ontributor to mortality. Whilethe involvement of immune inflammation in the dev elopment of cardiac ailments is well-documented, itsspecific impact on HCM path ogenesis remains uncertain.”
YunnanPeople’s Republic of ChinaAsiaBiomarkersCancerCardiologyCardiomyopathiesCardiovascularCardiovascul ar Diseases and ConditionsCyborgsDiagnostics and ScreeningEmerging Technol ogiesHealth and MedicineHeart DiseaseHeart Disorders and DiseasesHypertr ophic CardiomyopathyMachine LearningOncology
NETL
NSTL
